Moody National Bank Trust Division Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Moody National Bank Trust Division cut its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 17,505 shares of the healthcare conglomerate’s stock after selling 2,305 shares during the period. UnitedHealth Group accounts for about 0.3% of Moody National Bank Trust Division’s holdings, making the stock its 14th biggest position. Moody National Bank Trust Division’s holdings in UnitedHealth Group were worth $8,927,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of UnitedHealth Group by 1.9% during the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock worth $22,877,432,000 after buying an additional 869,827 shares during the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 4.3% during the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after buying an additional 790,219 shares during the last quarter. Geode Capital Management LLC boosted its position in UnitedHealth Group by 1.2% during the 4th quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock worth $7,821,210,000 after purchasing an additional 189,864 shares during the period. Alliancebernstein L.P. boosted its position in UnitedHealth Group by 2.4% during the 4th quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock worth $5,531,154,000 after purchasing an additional 257,910 shares during the period. Finally, Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter worth $4,478,185,000. Institutional investors and hedge funds own 87.48% of the company’s stock.

A number of analysts recently weighed in on UNH shares. Raymond James upped their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research report on Monday, April 18th. Cowen upped their price objective on shares of UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. StockNews.com assumed coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They issued a “strong-buy” rating for the company. Finally, Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $555.73.

In related news, Director Frederick William Mcnabb III acquired 89 shares of the stock in a transaction that occurred on Thursday, May 26th. The shares were acquired at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the purchase, the director now directly owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the transaction, the director now owns 1,220,000 shares in the company, valued at approximately $601,765,000. The disclosure for this sale can be found here. 0.40% of the stock is currently owned by company insiders.

UNH opened at $489.68 on Thursday. The firm has a market cap of $459.40 billion, a price-to-earnings ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The company’s 50-day moving average price is $496.56 and its 200 day moving average price is $490.86. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The firm had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. During the same quarter in the prior year, the business earned $5.31 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.2% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be paid a $1.65 dividend. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.35%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.